Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Impact of Genotype on Plasma and Cerebral Spinal Fluid Pharmacokinetics of Celecoxib in Children

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified August 2016 by Children's Hospital of Eastern Ontario
Sponsor:
Information provided by (Responsible Party):
Kimmo Murto, Children's Hospital of Eastern Ontario
ClinicalTrials.gov Identifier:
NCT01344200
First received: April 21, 2011
Last updated: August 17, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: August 2017
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)